Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$407M |
| 2 |
ExxonMobil
XOM
|
+$212M |
| 3 |
Microsoft
MSFT
|
+$200M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$183M |
| 5 |
Johnson & Johnson
JNJ
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$58.6M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$43M |
| 3 |
BCE
BCE
|
+$39M |
| 4 |
PETM
PETSMART INC
PETM
|
+$11.8M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.69% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 10.89% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Consumer Staples | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRXL
851
DELISTED
Parexel International Corp
PRXL
| $4.3M | 0.01% |
62,400
+900
| +1% | +$57.4K |
|
852
First American
FAF
$7.39B
| $4.29M | 0.01% |
120,100
+1,300
| +1% | +$45.2K |
|
853
Charles River Laboratories
CRL
$13.7B
| $4.27M | 0.01% |
53,900
+400
| +0.7% | +$29.5K |
|
|
DST
854
DELISTED
DST Systems Inc.
DST
| $4.27M | 0.01% |
77,200
-1,800
| -2% | -$92.5K |
|
|
UMPQ
855
DELISTED
Umpqua Holdings Corp
UMPQ
| $4.27M | 0.01% |
248,325
+10,800
| +5% | +$178K |
|
|
DNY
856
DELISTED
DONNELLEY R R & SONS CO
DNY
| $4.26M | 0.01% |
222,032
+2,200
| +1% | +$42.2K |
|
857
Tyler Technologies
TYL
$13B
| $4.25M | 0.01% |
35,300
+500
| +1% | +$57.3K |
|
858
Liberty Broadband Class C
LBRDK
$5.07B
| $4.25M | 0.01% |
75,124
+20,699
| +38% | +$1.05M |
|
859
Jack in the Box
JACK
$361M
| $4.25M | 0.01% |
44,300
| – | – |
|
860
United Natural Foods
UNFI
$2.94B
| $4.22M | 0.01% |
54,800
+800
| +1% | +$62.7K |
|
861
Vail Resorts
MTN
$5.27B
| $4.21M | 0.01% |
40,700
+500
| +1% | +$45.3K |
|
|
CAVM
862
DELISTED
Cavium, Inc.
CAVM
| $4.21M | 0.01% |
59,400
+800
| +1% | +$51.9K |
|
|
VRNT
863
DELISTED
Verint Systems
VRNT
| $4.21M | 0.01% |
133,288
+1,178
| +0.9% | +$34.6K |
|
864
Teledyne Technologies
TDY
$31.6B
| $4.19M | 0.01% |
39,300
| – | – |
|
|
CYT
865
DELISTED
CYTEC INDS INC
CYT
| $4.19M | 0.01% |
77,600
+1,000
| +1% | +$49.9K |
|
866
Manhattan Associates
MANH
$11.2B
| $4.18M | 0.01% |
82,700
+500
| +0.6% | +$24.1K |
|
867
Diamondback Energy
FANG
$56.2B
| $4.18M | 0.01% |
54,421
+2,500
| +5% | +$173K |
|
868
Old Republic International
ORI
$10.3B
| $4.17M | 0.01% |
279,300
+2,700
| +1% | +$39.6K |
|
869
Commerce Bancshares
CBSH
$8.52B
| $4.16M | 0.01% |
168,219
-6,499
| -4% | -$159K |
|
|
VVC
870
DELISTED
Vectren Corporation
VVC
| $4.15M | 0.01% |
94,100
+1,000
| +1% | +$45.8K |
|
|
AL
871
DELISTED
Air Lease Corp
AL
| $4.14M | 0.01% |
109,800
+1,000
| +0.9% | +$36.7K |
|
872
ITT
ITT
$19.4B
| $4.14M | 0.01% |
103,700
+1,000
| +1% | +$39.1K |
|
|
SGEN
873
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.12M | 0.01% |
116,500
+1,500
| +1% | +$51.2K |
|
|
ARRS
874
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $4.11M | 0.01% |
142,300
+1,300
| +0.9% | +$37K |
|
875
Guidewire Software
GWRE
$14.4B
| $4.1M | 0.01% |
77,850
+1,600
| +2% | +$82.9K |
|
Similar funds
Swiss National Bank's Q1 2015 Portfolio in Review
As of Q1 2015, Swiss National Bank held 2,582 positions worth $37.5B, up 40% from $26.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Swiss National Bank deployed $10.3B of net new capital in Q1 2015, opening 14 new positions and adding to 1,633 existing holdings. Its largest new stake was Infosys: 2,143,352 shares worth $18.8M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was BCE, an estimated $39M trimmed.
- Swiss National Bank's largest Q1 2015 buy was Infosys: 2,143,352 shares worth $18.8M.
- Swiss National Bank added most to Apple in Q1 2015, an estimated $407M increase.
- Swiss National Bank's biggest Q1 2015 reduction was BCE, cutting an estimated $39M.
- Swiss National Bank fully exited Allergan Inc in Q1 2015, selling an estimated $58.6M.
- Swiss National Bank's ten largest holdings make up 14% of its $37.5B portfolio in Q1 2015.
- Swiss National Bank opened 14 new positions and closed 36 in Q1 2015.
- Swiss National Bank's portfolio value rose 40% quarter-over-quarter to $37.5B.
Based on Swiss National Bank's 13F filing for Q1 2015, filed 6 May 2015.